{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:56:07Z","timestamp":1761918967427},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.2515\/therapie:2004096","type":"journal-article","created":{"date-parts":[[2007,3,16]],"date-time":"2007-03-16T09:12:58Z","timestamp":1174036378000},"page":"561-564","source":"Crossref","is-referenced-by-count":1,"title":["Agranulocytose sous loxapine chez une personne \u00e2g\u00e9e : \u00e9tude d\u2019un cas"],"prefix":"10.1016","volume":"59","author":[{"given":"Mich\u00e8le","family":"Hehn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orianne","family":"Labrune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Degouy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Duchene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Laroche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9deric","family":"Maloisel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Kantelip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2515\/therapie:2004096_bb1225","first-page":"525","article-title":"The drug etiology of agranulocytosis: an update of the international agranulocytosis and aplastic anemia study","volume":"2","author":"Kaufmann","year":"1993","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.2515\/therapie:2004096_bb1230","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/archinte.1992.00400190095018","article-title":"Descriptive epidemiology of agranulocytosis","volume":"152","author":"Strom","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.2515\/therapie:2004096_bb1235","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.1991.tb08042.x","article-title":"Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes","volume":"79","author":"Julia","year":"1991","journal-title":"Br J Haematol"},{"issue":"3","key":"10.2515\/therapie:2004096_bb1240","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0002-9343(86)90738-2","article-title":"Amoxapine associated agranulocytosis with thrombocytosis occuring early during recovery","volume":"80","author":"Sedlacek","year":"1986","journal-title":"Am J Med"},{"issue":"7","key":"10.2515\/therapie:2004096_bb1245","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1176\/ajp.140.7.921","article-title":"Agranulocytosis associated with amoxapine","volume":"140","author":"Christenson","year":"1983","journal-title":"Am J Psychiatry"},{"key":"10.2515\/therapie:2004096_bb1250","series-title":"Meyler\u2019s side effects of drugs","first-page":"139","article-title":"Neuroleptic and antipsychotic drugs","author":"Simpson","year":"2000"},{"key":"10.2515\/therapie:2004096_bb1255","first-page":"257","article-title":"Standardization of definitions and criteria for causality assessment of adverse drug reactions: drug-induced blood cytopenias: report of an international consensus meeting","volume":"33","author":"Benichou","year":"1993","journal-title":"Nouv Rev Fr Hematol"},{"issue":"6","key":"10.2515\/therapie:2004096_bb1260","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1399-0039.2003.00133.x","article-title":"NQO2 gene is associated with clozapine-induced agranulocytosis","volume":"62","author":"Ostrousky","year":"2003","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.2515\/therapie:2004096_bb1265","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/15622970310029918","article-title":"Morning pseudoneutropenia during clozapine treatment","volume":"4","author":"Esposito","year":"2003","journal-title":"World J Biol Psychiatry"},{"key":"10.2515\/therapie:2004096_bb1270","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1472-8206.1999.tb00329.x","article-title":"Comparative oxidation of loxapine and clozapine by human neutrophils","volume":"13","author":"Jegouzo","year":"1999","journal-title":"Fundam Clin Pharmacol"},{"key":"10.2515\/therapie:2004096_bb1275","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/BF00217059","article-title":"Cytotoxic effects of neuroleptic drugs","volume":"91","author":"Munyon","year":"1987","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.2515\/therapie:2004096_bb1280","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0953-6205(02)00085-7","article-title":"Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature","volume":"13","author":"Andres","year":"2002","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.2515\/therapie:2004096_bb1285","first-page":"470","article-title":"Prognostic factors of hematologic recovery in nonchemotherapy drug-induced agranulocytosis","volume":"88","author":"Maloisel","year":"2003","journal-title":"Haematologica"},{"key":"10.2515\/therapie:2004096_bb1290","first-page":"2031","article-title":"The application of hematopoietic growth factors in drug-induced agranulocytosis: review of 70 cases","volume":"8","author":"Sprikkelman","year":"1994","journal-title":"Leukemia"},{"key":"10.2515\/therapie:2004096_bb1295","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1592\/phco.19.4.299.30941","article-title":"Non chemotherapy drug induced agranulocytosis: a review of 118 patients treated with colony stimulating factors","volume":"19","author":"Beauchesne","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.2515\/therapie:2004096_bb1300","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/thy.1999.9.29","article-title":"Granulocyte colony stimulating factor does not improve recovery from antithyroid drug induced agranulocytosis: a prospective study","volume":"9","author":"Fukata","year":"1999","journal-title":"Thyroid"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716302414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716302414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T06:46:41Z","timestamp":1554274001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716302414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0040595716302414"],"URL":"https:\/\/doi.org\/10.2515\/therapie:2004096","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}